These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 2793996
41. Identification of lymphocyte subsets in peripheral blood and thyroid gland in Graves' disease by alpha-naphthyl-acetate-esterase reaction. Balázs C, Lévai M, Stenszky V, Farid NR. Acta Med Hung; 1986; 43(4):381-7. PubMed ID: 2439978 [Abstract] [Full Text] [Related]
42. Surface markers and function of circulating thyroid autoantibody-producing cells. Mariotti S, del Prete GF, Maggi E, Pisani S, Russova A, Almerigogna F, Pinchera A, Romagnani S, Ricci M. J Clin Endocrinol Metab; 1984 Jan; 58(1):18-24. PubMed ID: 6689680 [Abstract] [Full Text] [Related]
46. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice. Yoshikawa N, Arreaza G, Morita T, Mukuta T, Resetkova E, Akasu F, Miller N, Jamieson C, Volpé R. J Clin Endocrinol Metab; 1994 Feb; 78(2):367-74. PubMed ID: 8106624 [Abstract] [Full Text] [Related]
47. Analysis of peripheral T lymphocyte subpopulations in Graves' disease. Okabe N, Inoue K, Mori R. J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106 [Abstract] [Full Text] [Related]
48. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease]. Chen W, Man N, Li YS, Shan ZY, Teng WP. Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113 [Abstract] [Full Text] [Related]
49. Intrathyroidal lymphocytes from non toxic multinodular goiter: no evidence for production of thyroid stimulating antibodies. Mavilia C, Vallin E, Frediani U, Rotella CM, Toccafondi R. Autoimmunity; 1990 Feb; 6(4):239-48. PubMed ID: 1983328 [Abstract] [Full Text] [Related]
50. Immunological characterization of mononuclear cells in thyroid gland and blood in Graves' disease, multinodular goiter and papillary carcinoma. Aanderud S, Matre R, Varhaug JE. Int Arch Allergy Appl Immunol; 1982 Feb; 69(2):137-42. PubMed ID: 6896702 [Abstract] [Full Text] [Related]
51. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K. J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336 [Abstract] [Full Text] [Related]
52. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition. Nagata K, Hara S, Nakayama Y, Higaki K, Sugihara H, Kuwamoto S, Matsushita M, Kato M, Tanio S, Ishiguro K, Hayashi K. Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515 [Abstract] [Full Text] [Related]
53. Immunohistological phenotyping of thyroid infiltrating lymphocytes in Graves' disease and Hashimoto's thyroiditis. Misaki T, Konishi J, Nakashima T, Iida Y, Kasagi K, Endo K, Uchiyama T, Kuma K, Torizuka K. Clin Exp Immunol; 1985 Apr; 60(1):104-10. PubMed ID: 3891164 [Abstract] [Full Text] [Related]
54. The remarkable proliferation of helper T cell subset in response to autologous thyrocytes and intrathyroidal T cells from patients with Graves' disease. Eguchi K, Otsubo T, Kawabe Y, Ueki Y, Fukuda T, Matsunaga M, Shimomura C, Ishikawa N, Tezuka H, Nakao H. Clin Exp Immunol; 1987 Nov; 70(2):403-10. PubMed ID: 2962792 [Abstract] [Full Text] [Related]
55. Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Chrousos GP, Koutras DA. Thyroid; 2000 Jul; 10(7):527-32. PubMed ID: 10958304 [Abstract] [Full Text] [Related]
56. B- and T-lymphocytes in toxic diffuse goitre. Sköldstam L, Anderberg B, Norrby K. Clin Exp Immunol; 1978 Mar; 31(3):524-5. PubMed ID: 350461 [Abstract] [Full Text] [Related]
57. The expression of adhesion molecules in thyroid glands from patients with Graves' disease. Nakashima M, Eguchi K, Ida H, Yamashita I, Sakai M, Origuchi T, Kawabe Y, Ishikawa N, Ito K, Nagataki S. Thyroid; 1994 Mar; 4(1):19-25. PubMed ID: 7519914 [Abstract] [Full Text] [Related]
58. Effect of Graves' IgG on gene transcription in human thyroid cell cultures. Thyroglobulin gene activation. Kung AW, Collison K, Banga JP, McGregor AM. FEBS Lett; 1988 May 09; 232(1):12-6. PubMed ID: 2835260 [Abstract] [Full Text] [Related]
59. The SCID-hu mouse and thyroid autoimmunity: characterization of human thyroid autoantibody secretion. Davies TF, Kimura H, Fong P, Kendler D, Shultz LD, Thung S, Martin A. Clin Immunol Immunopathol; 1991 Aug 09; 60(2):319-30. PubMed ID: 2070573 [Abstract] [Full Text] [Related]
60. Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease. Grubeck-Loebenstein B, Londei M, Greenall C, Pirich K, Kassal H, Waldhäusl W, Feldmann M. J Clin Invest; 1988 May 09; 81(5):1608-14. PubMed ID: 3130398 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]